CA1059914A - Pharmaceutical preparation for the treatment of circulatory disorders - Google Patents

Pharmaceutical preparation for the treatment of circulatory disorders

Info

Publication number
CA1059914A
CA1059914A CA242,910A CA242910A CA1059914A CA 1059914 A CA1059914 A CA 1059914A CA 242910 A CA242910 A CA 242910A CA 1059914 A CA1059914 A CA 1059914A
Authority
CA
Canada
Prior art keywords
active compound
acid
pharmaceutical preparation
slow
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA242,910A
Other languages
English (en)
French (fr)
Inventor
Peter R. Imhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA1059914A publication Critical patent/CA1059914A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA242,910A 1975-01-06 1976-01-02 Pharmaceutical preparation for the treatment of circulatory disorders Expired CA1059914A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06
CH1474775 1975-11-13

Publications (1)

Publication Number Publication Date
CA1059914A true CA1059914A (en) 1979-08-07

Family

ID=25683420

Family Applications (1)

Application Number Title Priority Date Filing Date
CA242,910A Expired CA1059914A (en) 1975-01-06 1976-01-02 Pharmaceutical preparation for the treatment of circulatory disorders

Country Status (10)

Country Link
JP (1) JPS5191314A (de)
AU (1) AU499139B2 (de)
BE (1) BE837294A (de)
CA (1) CA1059914A (de)
DE (1) DE2600021A1 (de)
FR (1) FR2296415A1 (de)
GB (1) GB1500300A (de)
IE (1) IE42765B1 (de)
IL (1) IL48787A (de)
NL (1) NL7600047A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981563A (en) * 1995-04-28 1999-11-09 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
IN151913B (de) * 1980-01-11 1983-09-03 Boots Co Ltd
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
KR20090037951A (ko) * 2006-07-25 2009-04-16 교와 가부시키가이샤 당의 제제 및 그의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL51480C (de) *
FR1013681A (fr) * 1947-01-31 1952-08-01 Ciba Geigy Nouvelles imidazolines et procédé pour leur fabrication

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981563A (en) * 1995-04-28 1999-11-09 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6051594A (en) * 1995-04-28 2000-04-18 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6100286A (en) * 1995-04-28 2000-08-08 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6124337A (en) * 1995-04-28 2000-09-26 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6166061A (en) * 1995-04-28 2000-12-26 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Also Published As

Publication number Publication date
IE42765L (en) 1976-07-06
BE837294A (fr) 1976-07-05
AU1000176A (en) 1977-07-14
NL7600047A (nl) 1976-07-08
IL48787A (en) 1978-09-29
FR2296415B1 (de) 1978-08-18
GB1500300A (en) 1978-02-08
AU499139B2 (en) 1979-04-05
IE42765B1 (en) 1980-10-08
DE2600021A1 (de) 1976-07-15
FR2296415A1 (fr) 1976-07-30
IL48787A0 (en) 1976-03-31
JPS5191314A (de) 1976-08-10

Similar Documents

Publication Publication Date Title
CA1255223A (en) Pellet formulation
AU652871B2 (en) Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
CA1339072C (en) Pharmaceutical formulation as well as a process for its preparation
CA2074309C (en) Stabilized controlled release formulations having acrylic polymer coating
US4507276A (en) Analgesic capsule
US5296232A (en) Pharmaceutical formulation which does not induce tolerance
US4784858A (en) Controlled release tablet
US8747898B2 (en) Controlled release oral dosage form
AU596804B2 (en) A granular delayed-release form of pharmaceutically active substances
RU2122413C1 (ru) Форма фармацевтического дозирования, обеспечивающая продолжительное выделение активного ингредиента
KR100716410B1 (ko) 토피라메이트 서방성 제제 및 그의 제조방법
EP1453487B1 (de) Mehrfach beschichete pharmazeutische dosierungsform
US6468560B2 (en) Controlled release dosage form of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
EP1140105A1 (de) Galantamin-zusammensetzung mit gesteuerter freisetzung
EP0377517A2 (de) Theophyllin-Dosisform
SK278868B6 (sk) Prípravok s retardovaným uvoľňovaním účinnej látky
CA1059914A (en) Pharmaceutical preparation for the treatment of circulatory disorders
CA2265661A1 (en) Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2.2oct-c-yl)acetonitrile monohydrochloride
US4968506A (en) Pharmaceutical dosage with core of N-acetyl cystein
NO149874B (no) Fremgangsmaate for fremstilling av et pindololholdig farmasoeytisk produkt
IE49323B1 (en) Galenical compositions
JPH04338323A (ja) 放出制御製剤およびその製造法
IE46241B1 (en) Process for the preparation of antidiarrheal agents
KR100341664B1 (ko) 제어방출형 아미트리프틸린 과립 및 그의 제조방법
CN115414333A (zh) 一种多廿烷醇阿司匹林复方制剂及其制备方法